RN2 Technologies announced on November 14 that it will officially transition to a digital asset-based financial infrastructure, along with the appointment of new board members.
RN2 Technologies recently disclosed through an electronic filing that it has appointed new internal and external directors and significantly expanded its business objectives to include blockchain and digital asset-related ventures.
The newly appointed board members include a director from Binance Global Exchange, a lawyer who previously worked as a fund manager in the traditional financial market, and the Chief Financial Officer (CFO) of PharmaResearch. The board is composed of individuals with expertise in the global blockchain market, as well as in finance and law.
Previously a traditional manufacturing and technology company, RN2 Technologies has declared its transformation into a "digital asset financial company," going beyond simply adopting blockchain technology. The company will focus on areas such as Digital Asset Treasury (DAT), digital asset custody and institutional prime brokerage services, and stablecoin distribution.
A company representative explained, "With the new board at the center, we will maximize synergies between our existing business and the digital asset financial infrastructure business." The representative added, "Given the board's deep understanding of the digital asset market and institutional financial business, we expect this to form the foundation for the company's ongoing new business transformation."
RN2 Technologies plans to further refine its new business structure following an extraordinary shareholders' meeting in December and to gradually launch its digital asset financial platform starting in 2026.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
